HLA-G Expression Pattern: Reliable Assessment for Pregnancy Outcome Prediction.

Because mothers and fathers are more or less dissimilar at multiple HLA loci, mother considers her fetus as a semi-allograft. Mother's immune system may recognize paternal HLA as foreign antigen and may develop anti-paternal HLA antibodies and cytotoxic T lymphocyte. There are some mechanisms that modulate maternal immune responses during pregnancy, in order to make uterus an immune privileged site. This immunosuppression is believed to be mediated, at least partly, by HLA-G, non-classical class I human leukocyte antigen (HLA) molecule that is strongly expressed in cytotrophoblast and placenta. The major HLA-G function is its ability to inhibit T and B lymphocytes, NK cells and antigen-presenting cells (APC).Since HLA-G is expressed strongly at the maternofetal interface and has an essential role in immunosuppression, HLA-G polymorphism and altered expression of HLA-G seems to be associated with some complications of pregnancy, such as pre-eclampsia, recurrent misscariage and failure in IVF.This perspective discusses recent findings about HLA-G genetics, function, expression and polymorphism; and focus on HLA-G role in the etiology of recurrent miscarriage.

[1]  T. Hviid HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. , 2006, Human reproduction update.

[2]  P. Stone,et al.  Comparison of the expression of human leukocyte antigen (HLA)-G and HLA-E in women with normal pregnancy and those with recurrent miscarriage. , 2006, Reproduction.

[3]  L. Regan,et al.  Recurrent miscarriage. , 2006, Lancet.

[4]  C. Ober,et al.  HLA‐G and immune tolerance in pregnancy , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  O. Christiansen,et al.  HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms , 2004, Immunogenetics.

[6]  J. Dausset,et al.  HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  O. Sandra,et al.  TH1/TH2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/early abortion: reexamining the TH1/TH2 paradigm. , 2004, International archives of allergy and immunology.

[8]  D. Geraghty,et al.  Protein Expression and Peptide Binding Suggest Unique and Interacting Functional Roles for HLA-E, F, and G in Maternal-Placental Immune Recognition 1 , 2003, The Journal of Immunology.

[9]  C. Ober,et al.  Variation in the HLA-G promoter region influences miscarriage rates. , 2003, American journal of human genetics.

[10]  T. Hviid,et al.  HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels , 2003, Immunogenetics.

[11]  S. Ferrone,et al.  Soluble HLA‐A,‐B,‐C and ‐G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation , 2003, European journal of immunology.

[12]  K. Ahn,et al.  The truncated cytoplasmic tail of HLA-G serves a quality-control function in post-ER compartments. , 2001, Immunity.

[13]  R. Silver,et al.  Recurrent Pregnancy Loss: Summary and Clinical Recommendations , 2000, Seminars in reproductive medicine.

[14]  J. Dausset,et al.  HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. , 1999, International immunology.

[15]  R. Biassoni,et al.  Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. McMichael,et al.  Tetrameric Complexes of Human Histocompatibility Leukocyte Antigen (HLA)-G Bind to Peripheral Blood Myelomonocytic Cells , 1999, The Journal of experimental medicine.

[17]  C. Ober,et al.  HLA-G1 protein expression is not essential for fetal survival. , 1998, Placenta.

[18]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[19]  N. Morling,et al.  Co-dominant expression of the HLA-G gene and various forms of alternatively spliced HLA-G mRNA in human first trimester trophoblast. , 1998, Human immunology.

[20]  C. Ober,et al.  HLA-G polymorphisms: neutral evolution or novel function? , 1997, Journal of reproductive immunology.

[21]  Y. W. Loke,et al.  Immunology of human placental implantation: clinical implications of our current understanding. , 1997, Molecular medicine today.

[22]  D. Geraghty,et al.  Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Coulam Epidemiology of Recurrent Spontaneous Abortion , 1991, American journal of reproductive immunology.

[24]  H. Orr,et al.  HLA non-A,B,C class I genes: Their structure and expression , 1990, Immunologic research.

[25]  M. Biteker Current understanding , 1990, The Lancet.

[26]  G. Stirrat Recurrent miscarriage. , 1990, Lancet.

[27]  G. Andrews,et al.  Normal trophoblasts resist induction of class I HLA. , 1987, Journal of immunology.

[28]  D. Edmonds,et al.  Early embryonic mortality in women , 1982 .